Answers are grounded in this paper and cite their sources.
// Zhiqiang Chen 1, 2, * , Yi Zheng 2, * , Guanghai Ji 2 , Xinxin Liu 3 , Peng Li 2 , Lei Cai 2 , Yulin Guo 2 and Jian Yang 1 1 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China 2 Radiology Department of The General Hospital, Ningxia Medical University, Yinchuan 750004, Ningxia, China 3 Department of Diagnostic Imaging, Honghui Hospital, Health Science Center of Xi'an Jiaotong University, Xi'an 750004, Shaanxi, China * These authors contributed equally to this work Correspondence to: Jian Yang, email: yj1118@mail.xjtu.edu.cn Keywords: diagnostic imaging, diagnostic techniques, early detection of cancer, magnetic resonance imaging, male Received: March 03, 2017 Accepted: August 04, 2017 Published: August 17, 2017 ABSTRACT The goals of this meta-analysis were to assess the effectiveness of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in patients with prostate carcinoma (PCa) and to explore the risk profiles with the highest benefit. Systematic electronic searched were conducted in database. We used patient-based and biopsy-based pooled weighted estimates of the sensitivity, specificity, and a summary receiver operating characteristic (SROC) curve for assessing the diagnostic performance of DCE. We performed direct and indirect comparisons of DCE and other methods of imaging. A total of 26 articles met the inclusion criteria for the analysis. DCE-MRI pooled sensitivity was 0.53 (95% CI 0.39 to 0.67), with a specificity of 0.88 (95% CI 0.83 to 0.92) on whole gland. The peripheral zone pooled sensitivity was 0.70 (95% CI 0.46 to 0.86), with a specificity of 0.88 (95% CI 0.76 to 0.94). Compared with T2-weighted imaging (T2WI), DCE was statistically superior to T2. In conclusion, DCE had relatively high specificity in detecting PCa but relatively low sensitivity as a complementary functional method. DCE-MRI might help clinicians exclude cases of normal tissue and serve as an adjunct to conventional imaging when seeking to identify tumor foci in patients with PCa.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: